SBIR/STTR Research Award
Infrared Eyes
Award amount
$151,988Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- EDEN MEDICAL, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- KJGKLJKBEEG3
- Solicitation number
- PA14-071
- Topic code
- NIDDK
Research abstract
DESCRIPTION (provided by applicant): Eden Medical, Inc. is pleased to submit this Phase 1 SBIR proposal to develop the Infrared Eyes (iREyes) imager system, an affordable and powerful mobile health (mhealth) tool for healthcare. The hand-held iREyes system will acquire both thermal and visible spectrum imagery to quantify healing via foot thermal indexing methodology. The iREyes will offer a user-friendly product with a significantly lower cost (lt 500) than today's existing infrared microbolometer technology. The iREyes will also identify hot spots associated with repetitive stress to reduce ulceration risk. Diabetic foot wounds are common, complex and costly. Foot areas that are likely to ulcerate are associated with increased local skin temperature dueto inflammation and enzymatic autolysis of tissue. Inflammation is characterized by the cardinal signs including redness, swelling, and heat. iREyes will directly quantify inflammation pathophysiology through contralateral and regional foot index image
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Smart Foot Mat
- Diabetic Foot Imaging Scanner(DFIS)
- Self-Sealing Therapy Ostomy Pouch (S2TOP)
- Foot Infrared Rolling Scan Transducer (FIRST)
- Diabetic Foot Imaging Scanner(DFIS)
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
- Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
- Novel Over-the-Scope Platform for Control of Variceal Bleeding
- Tolerogenic Nanotherapy to Delay Type I Diabetes
- An intravascular Bioartificial Pancreas (iBAP)
Research funding history
6 SBIR/STTR records share this UEI (2009–2024). Reported award amounts total $2,619,890. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services